ArticleJID innovations : skin science from molecules to population health2025
Assessment of Primary Malignancy Risk after Initiation of Biologic Therapy in Patients with Psoriasis.
Chunghwan Ro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.